cgp 52411 has been researched along with rottlerin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colby, DW; Collins, SR; Feng, BY; May, BC; Prusiner, SB; Shoichet, BK; Toyama, BH; Weissman, J; Wille, H | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Deng, B; Nie, R; Wang, J; Xia, Z; Xie, S | 1 |
3 other study(ies) available for cgp 52411 and rottlerin
Article | Year |
---|---|
Small-molecule aggregates inhibit amyloid polymerization.
Topics: Acetophenones; Animals; Benzopyrans; beta-Lactamase Inhibitors; beta-Lactamases; Clioquinol; Congo Red; Detergents; Flavanones; Mice; Microscopy, Electron, Transmission; Molecular Structure; Molecular Weight; Particle Size; Peptide Termination Factors; Phenolphthaleins; Phthalimides; Prions; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sensitivity and Specificity; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Inhibition of protein kinase C β(2) prevents tumor necrosis factor-α-induced apoptosis and oxidative stress in endothelial cells: the role of NADPH oxidase subunits.
Topics: Acetophenones; Apoptosis; Benzopyrans; Human Umbilical Vein Endothelial Cells; Humans; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Phthalimides; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Protein Subunits; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |